We have manufacturers, suppliers and service providers from the area Cardiovascular surgery products (other)

ATS Medical specializes in producing cardiovascular surgery products. The company has product sales in 40 countries and has manufactured 80,000 mechanical heart valves. Its ATS Open Pivot(r) Heart Valve features open pivots on smooth spheres. This unique design allows leaflets to pivot in their slots. The implanted device is made of titanium and features a large diameter to accommodate the anatomy of the patient. It can also be used for a variety of other procedures.

Sorin S.p.A., a medical technology company in Massachusetts, specializes in small bore vascular grafts. Their vascular grafts are made of biocompatible ChronoFlex polyurethane and can be used to replace damaged arteries. The company is also developing a layered microporous coronary artery bypass graft. Gish Biomedical, Inc., a California-based company, produces disposable specialty surgical devices.

COBE Cardiovascular, Inc., a leading distributor of cardiac surgery systems, is a global manufacturer of surgical instruments and equipment. Its portfolio of products includes heart-lung tubing packs, autotransfusion systems, and heart-lung machines. The company was formed in 1992 when COBE Laboratories focused on custom heart-lung tubing packs. After the merger, COBE expanded its product offerings to include cardiovascular surgery and blood component technologies.

Sorin Biomedica, a Swedish corporation, spun off its cardiovascular division in 2000. In 2004, the company restructured its holdings into business units. In 2005, the cardiovascular division was spun off into COBE. This new entity was merged into SNIA's Medical Technology division. Its current portfolio of specialty surgical equipment includes the COBE Cardiovascular device. These surgical devices are manufactured by a number of companies.

Surge Cardiovascular was acquired by MED Michigan Holdings, LLC, in March 2015. Its operations will remain independent of the company. MED Michigan Holdings has been the exclusive clinical specialty distributor for Surge Cardiovascular since 2012. In March 2020, it will be the sole distributor of 3T Medical's assets. Formeda's patented, and highly effective medical devices are the foundation of the company. The company's portfolio is the largest in the United States.

Lepu has a diverse portfolio of cardiovascular surgery products. It manufactures an implantable pacemaker, occlusion devices, and a variety of other medical devices. Its occlusion products are marketed to patients, while its prosthetic heart valves are used for other surgeries. Its endovascular and interventional devices include a wide range of hemostasis. The company's product line also includes a variety of anesthetics.

In addition to supplying cardiovascular surgical products, Terumo also provides technology for hospitals. Their technologies include wound care, surgical technology, and infection control. They have become the leading medical device supplier worldwide. However, their cardiovascular business has underperformed the industry. In fact, the company has one of the worst performing medical devices companies in the world. In January 2020, MED Alliance Solutions will become the exclusive clinical specialty distributor for 3T Medical's assets.

Several major pharmaceutical companies have partnered with Terumo to develop a regenerative therapy for the heart. The company's products include a stent that can be inserted through a vein without cutting it open. In addition, the company has developed a catheter that can repair and replace existing heart valves. With these technologies, Terumo is making a difference in the lives of many patients. For instance, it has developed a device called the Terumo HeartSheet.

Another cardiovascular surgery product provider, Terumo, recently announced a partnership with Monmouth Junction, N.J.-based CytoSorbents Corp., the company will sell CytoSorb to hospitals in 10 COVID-19-hotspot states. The drug was previously approved by the FDA for use in critically ill COVID-19 patients. In addition, Terumo has launched a new regenerative therapy known as the Terumo HeartSheet.

The Terumo device was the first commercially available device. It works by taking over the functions of the heart and lungs. The device can exchange gasses including oxygen and returns the blood oxygenated. Moreover, the Terumo device has a long list of uses. The company offers a variety of innovative surgical solutions for the heart. The COBE Spectra Apheresis System is one of the most popular in the world.